Shares of CVS Health Co. (NYSE:CVS – Get Rating) have been assigned a consensus recommendation of “Buy” from the twenty-five research firms that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $113.09.
Several analysts have weighed in on CVS shares. Deutsche Bank Aktiengesellschaft cut shares of CVS Health from a “buy” rating to a “hold” rating and set a $110.00 price objective on the stock. in a research note on Tuesday, March 29th. Truist Financial upped their price objective on shares of CVS Health from $118.00 to $124.00 and gave the stock a “buy” rating in a research note on Wednesday, January 5th. Robert W. Baird upped their price objective on shares of CVS Health from $107.00 to $110.00 in a research note on Wednesday, January 12th. Sanford C. Bernstein upped their price objective on shares of CVS Health from $111.00 to $116.00 in a research note on Tuesday, January 11th. Finally, BMO Capital Markets upped their price objective on shares of CVS Health from $108.00 to $120.00 in a research note on Thursday, February 10th.
In other news, Director Edward J. Ludwig bought 1,000 shares of the business’s stock in a transaction on Thursday, February 10th. The shares were bought at an average cost of $105.90 per share, for a total transaction of $105,900.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Jonathan C. Roberts sold 68,482 shares of the stock in a transaction on Thursday, January 27th. The stock was sold at an average price of $107.50, for a total transaction of $7,361,815.00. The disclosure for this sale can be found here. Insiders sold 226,147 shares of company stock worth $23,949,067 over the last 90 days. 0.69% of the stock is currently owned by company insiders.
NYSE CVS opened at $101.68 on Monday. The stock has a market cap of $133.53 billion, a P/E ratio of 17.06, a PEG ratio of 1.58 and a beta of 0.80. The company’s 50-day simple moving average is $104.25 and its 200 day simple moving average is $99.80. CVS Health has a twelve month low of $74.97 and a twelve month high of $111.25. The company has a quick ratio of 0.62, a current ratio of 0.88 and a debt-to-equity ratio of 0.69.
CVS Health (NYSE:CVS – Get Rating) last posted its earnings results on Wednesday, February 9th. The pharmacy operator reported $1.98 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.94 by $0.04. The business had revenue of $76.60 billion for the quarter, compared to analysts’ expectations of $76.01 billion. CVS Health had a net margin of 2.71% and a return on equity of 15.15%. During the same quarter in the previous year, the firm posted $1.30 earnings per share. Research analysts anticipate that CVS Health will post 8.23 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, May 2nd. Investors of record on Friday, April 22nd will be issued a $0.55 dividend. The ex-dividend date of this dividend is Thursday, April 21st. This represents a $2.20 annualized dividend and a yield of 2.16%. CVS Health’s dividend payout ratio is currently 36.91%.
About CVS Health (Get Rating)
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- Schwab Stock Can Be Caught Down Here
- Snap Up Some Snap-On On Post-Earnings Weakness
- Time to Buy any Dip in Prologis Stock
- 3 Resilient Stocks to Buy for Retirement
- MarketBeat: Week in Review 4/18 – 4/22
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.